tradingkey.logo

tradingkey.logo
怜玢


Advanced Biomed Inc

ADVB
りォッチリストに远加
4.400USD
-0.030-0.68%
終倀 05/15, 16:00ET15分遅れの株䟡
7.19M時䟡総額
1.11盎近12ヶ月PER


詳现情報 Advanced Biomed Inc 䌁業名

Advanced Biomed Inc. is a holding company that operates, through its subsidiaries, Advanced Biomed Inc. (Taiwan) and Advanced Biomed HK Limited. The Company is engaged in the provision of assay products and services for cancer patients. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. It has developed a microfluidic technology platform to integrate research and development, design, and manufacture of biochips and microfluidic chips. The platform combines its patented chip technology and will enable localized operations of a variety of microfluidic chips, biosensors made by semiconductor fabrication technology, and integrated application patented technology. The Company offers devices, such as A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre-Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip.

Advanced Biomed Incの䌁業情報


䌁業コヌドADVB
䌚瀟名Advanced Biomed Inc
䞊堎日Mar 06, 2025
最高経営責任者「CEO」- -
埓業員数31
蚌刞皮類Ordinary Share
決算期末Mar 06
本瀟所圚地401 Ryland St
郜垂RENO
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号89502
電話番号1862120510823
りェブサむトhttp://www.advanbiomed.com/
䌁業コヌドADVB
䞊堎日Mar 06, 2025
最高経営責任者「CEO」- -

Advanced Biomed Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. I-Fang (Steven) Cheng, Ph.D.
Dr. I-Fang (Steven) Cheng, Ph.D.
Chief Technology Officer, Director
Chief Technology Officer, Director
--
--
Mr. Alan
Mr. Alan
Director of Investor Relations
Director of Investor Relations
--
--
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. I-Fang (Steven) Cheng, Ph.D.
Dr. I-Fang (Steven) Cheng, Ph.D.
Chief Technology Officer, Director
Chief Technology Officer, Director
--
--
Mr. Alan
Mr. Alan
Director of Investor Relations
Director of Investor Relations
--
--

収益内蚳

䌚瀟から関連デヌタがただ開瀺されおいたせん。
䌚瀟から関連デヌタがただ開瀺されおいたせん。
事業別
地域別
䌚瀟から関連デヌタがただ開瀺されおいたせん。

株䞻

曎新時刻: Sun, Feb 1
曎新時刻: Sun, Feb 1
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
Lu (Yi Ph.D.)
20.52%
Pau (Hung To)
10.78%
Advance on Ventures Ltd
6.68%
Luo (Xiaoyuan)
4.28%
Zhu (Beili)
3.70%
他の
54.04%
株䞻統蚈
株䞻統蚈
比率
Lu (Yi Ph.D.)
20.52%
Pau (Hung To)
10.78%
Advance on Ventures Ltd
6.68%
Luo (Xiaoyuan)
4.28%
Zhu (Beili)
3.70%
他の
54.04%
皮類
株䞻統蚈
比率
Individual Investor
39.28%
Corporation
6.68%
Venture Capital
0.08%
Research Firm
0.04%
他の
53.92%

機関投資家保有株


曎新時刻: Wed, Apr 1
曎新時刻: Wed, Apr 1
報告期間
機関投資家数
保有株匏数
比率
倉動額
2026Q1
6
1.99K
0.12%
-12.43K
2025Q4
6
262.83K
0.61%
--
2025Q3
6
262.83K
0.61%
+131.46K
2025Q2
4
131.38K
0.05%
+120.16K
2025Q1
1
11.21K
0.00%
+11.21K

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
Lu (Yi Ph.D.)
335.40K
24.58%
--
--
Jan 08, 2026
Pau (Hung To)
176.22K
12.91%
--
--
Jan 08, 2026
Advance on Ventures Ltd
109.20K
8%
--
--
Jan 08, 2026
Luo (Xiaoyuan)
69.90K
5.12%
--
--
Jan 08, 2026
Zhu (Beili)
60.45K
4.43%
+60.45K
--
Jan 08, 2026
XTX Markets LLC
1.36K
0.1%
-1.25K
-47.82%
Dec 31, 2025
Virtu Americas LLC
628.00
0.05%
-974.00
-60.80%
Dec 31, 2025
UBS Financial Services, Inc.
216.00
0.02%
+48.00
+28.57%
Dec 31, 2025
Citadel Advisors LLC
--
0%
-6.98K
-100.00%
Dec 31, 2025
Renaissance Technologies LLC
--
0%
-1.23K
-100.00%
Sep 30, 2025
詳现を芋る

関連ETF


銘柄名
比率
デヌタなし

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
配圓萜ち日
皮類
比率
Jan 23, 2026
Merger
20→1
日付
配圓萜ち日
皮類
比率
Jan 23, 2026
Merger
20→1
KeyAI
î™